Skip to content
10-Q

Quarterly Report

Lexeo Therapeutics, Inc. LXEO

0000950170-25-108427

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 54M sh
Shares Diluted Q2 2025 · Jun 30, 2025 43.57M sh
Shares Diluted Q2 2025 · Jun 30, 2025 38.37M sh
Shares Diluted Q2 2025 · Jun 30, 2024 33M sh
Shares Diluted Q2 2025 · Jun 30, 2024 30.49M sh
Capex Q2 2025 · Jun 30, 2025 $108K
Capex Q2 2025 · Jun 30, 2024 $398K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$48.94M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$35.02M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $35.48M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $35.01M
Stockholders Equity Q2 2025 · Jun 30, 2025 $138.22M
Stockholders Equity Q2 2025 · Mar 31, 2025 $88.12M
Stockholders Equity Q2 2025 · Dec 31, 2024 $116.84M
Stockholders Equity Q2 2025 · Jun 30, 2024 $164.95M
Stockholders Equity Q2 2025 · Mar 31, 2024 $182.95M
Stockholders Equity Q2 2025 · Dec 31, 2023 $113.54M
Current Liabilities Q2 2025 · Jun 30, 2025 $31.59M
Current Liabilities Q2 2025 · Dec 31, 2024 $22.85M
Total Liabilities Q2 2025 · Jun 30, 2025 $37.85M
Total Liabilities Q2 2025 · Dec 31, 2024 $30.1M
Current Assets Q2 2025 · Jun 30, 2025 $140.06M
Current Assets Q2 2025 · Dec 31, 2024 $126.12M
Total Assets Q2 2025 · Jun 30, 2025 $176.07M
Total Assets Q2 2025 · Dec 31, 2024 $146.94M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.60
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.53
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.64
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.41
Eps Basic Q2 2025 · Jun 30, 2025 −$0.60
Eps Basic Q2 2025 · Jun 30, 2025 −$1.53
Eps Basic Q2 2025 · Jun 30, 2024 −$0.64
Eps Basic Q2 2025 · Jun 30, 2024 −$1.41
Sga Expense Q2 2025 · Jun 30, 2025 $15.97M
Sga Expense Q2 2025 · Jun 30, 2025 $32.6M
Sga Expense Q2 2025 · Jun 30, 2024 $6.99M
Sga Expense Q2 2025 · Jun 30, 2024 $14.54M
Rd Expense Q2 2025 · Jun 30, 2025 $14.72M
Rd Expense Q2 2025 · Jun 30, 2025 $31.89M
Rd Expense Q2 2025 · Jun 30, 2024 $16.56M
Rd Expense Q2 2025 · Jun 30, 2024 $32.3M
Net Income Q2 2025 · Jun 30, 2025 −$26.1M
Net Income Q2 2025 · Jun 30, 2025 −$58.76M
Net Income Q2 2025 · Mar 31, 2025 −$32.66M
Net Income Q2 2025 · Dec 31, 2024 −$98.3M
Net Income Q2 2025 · Jun 30, 2024 −$21.24M
Net Income Q2 2025 · Jun 30, 2024 −$42.92M
Net Income Q2 2025 · Mar 31, 2024 −$21.68M
Operating Income Q2 2025 · Jun 30, 2025 −$30.69M
Operating Income Q2 2025 · Jun 30, 2025 −$64.49M
Operating Income Q2 2025 · Jun 30, 2024 −$23.55M
Operating Income Q2 2025 · Jun 30, 2024 −$46.84M